THROMBIN GENERATION TEST IN PATIENTS UNDER NEW ORAL ANTICOAGULANTS (DABIGATRAN AND RIVAROXABAN)

被引：0
|
作者：
Cabrera, N. [1 ]
Moret, A. [1 ]
Mesa, E. [1 ]
Vila, V. [1 ]
Mira, Y. [1 ]
Ferrando, F. [1 ]
Aznar, Jose A. [1 ]
Bonanad, S. [1 ]
机构：
[1] Hosp Univ & Politecn La Fe, Inst Invest Sanitaria La Fe, Unidad Hemostasia & Trombosis, Valencia, Spain
来源：
THROMBOSIS RESEARCH | 2014年 / 133卷
关键词：
D O I：
10.1016/S0049-3848(14)50148-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C0416
引用
收藏
页码：S43 / S44
页数：2
相关论文
共 50 条
  • [41] Dabigatran Etexilate A New Oral Thrombin Inhibitor
    Hankey, Graeme J.
    Eikelboom, John W.
    CIRCULATION, 2011, 123 (13) : 1436 - 1450
  • [42] Propagation of thrombin generation in space reveals difference in effects of heparin, dabigatran and rivaroxaban
    Dashkevich, N.
    Pivovarova, E.
    Ataullakhanov, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 24 - 25
  • [43] 'In vitro' response of dabigatran and rivaroxaban on thrombin generation (CAT) and fibrin formation (ROTEM)
    Samama, M. M.
    Guinet, C.
    Le Flem, L.
    Gerotziafas, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 380 - 381
  • [44] New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) and Vitamin K Antagonists: Incidence and Treatment Patterns in 2012 in France
    Maura, G.
    Billionnet, C.
    Weill, A.
    Ricordeau, P.
    Alla, F.
    Allemand, H.
    DRUG SAFETY, 2013, 36 (09) : 836 - 836
  • [45] What is the best time sampling for the two direct oral anticoagulants (DOACs), dabigatran and rivaroxaban?
    Douxfils, J.
    Baudar, J.
    Devalet, B.
    Samama, M. M.
    Chatelain, B.
    Dogne, J-M
    Mullier, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 9 - 10
  • [46] COMPARISON OF COSTS AND HEALTHCARE UTILIZATION BETWEEN PATIENTS USING NOVEL ORAL ANTICOAGULANTS (DABIGATRAN & RIVAROXABAN) VERSUS WARFARIN
    Deshpande, C. G.
    Temkin, Willey C.
    Kogut, S.
    Laforge, R.
    VALUE IN HEALTH, 2017, 20 (05) : A268 - A268
  • [47] Reverse engineering for new oral anticoagulants: Non-specific reversal agents and the anticoagulant activity of dabigatran and rivaroxaban
    Levi, Marcel
    THROMBOSIS AND HAEMOSTASIS, 2012, 108 (02) : 201 - 202
  • [48] Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran
    Al-Ghafry, Maha
    Sharathkumar, Anjali
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [49] Effects of new oral anticoagulants on fibrin-network permeability and thrombin generation
    Skeppholm, M.
    Zabczyk, M.
    Al-Khalili, F.
    Malmstrom, R.
    Agren, A.
    Blomback, M.
    He, S.
    Wallen, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 396 - 396
  • [50] Monitoring drug activity of dabigatran and rivaroxaban by thrombin generation using the calibrated automated thrombinoscope
    Moret, A.
    Cabrera, N.
    Mira, Y.
    Ferrando, F.
    Haya, S.
    Cid, A. R.
    Mesa, E.
    Hernani, R.
    Vila, V.
    Bonanad, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 961 - 962
12345